KNOTUS Co.Ltd (278650) - Total Liabilities
Based on the latest financial reports, KNOTUS Co.Ltd (278650) has total liabilities worth ₩44.24 Billion KRW (≈ $29.98 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
KNOTUS Co.Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how KNOTUS Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 278650 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
KNOTUS Co.Ltd Competitors by Total Liabilities
The table below lists competitors of KNOTUS Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sam Young Chem
KO:003720
|
Korea | ₩112.72 Billion |
|
Melar Acquisition Corp. I Unit
NASDAQ:MACIU
|
USA | $10.89 Million |
|
Premier Marketing Public Company Limited
BK:PM
|
Thailand | ฿1.48 Billion |
|
HIL Limited
NSE:HIL
|
India | Rs17.14 Billion |
|
Zeng Hsing Industrial Co Ltd
TW:1558
|
Taiwan | NT$4.64 Billion |
|
CVW CleanTech Inc
V:CVW
|
Canada | CA$861.47K |
|
WEST RED LAKE GOLD MINES
F:UJ0
|
Germany | €176.71 Million |
|
Owens & Minor Inc
NYSE:OMI
|
USA | $4.47 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down KNOTUS Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of KNOTUS Co.Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how KNOTUS Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for KNOTUS Co.Ltd (2016–2024)
The table below shows the annual total liabilities of KNOTUS Co.Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩56.45 Billion ≈ $38.26 Million |
-17.15% |
| 2023-12-31 | ₩68.14 Billion ≈ $46.18 Million |
-33.14% |
| 2022-12-31 | ₩101.91 Billion ≈ $69.06 Million |
+239.26% |
| 2021-12-31 | ₩30.04 Billion ≈ $20.36 Million |
+46.02% |
| 2020-12-31 | ₩20.57 Billion ≈ $13.94 Million |
+4.60% |
| 2019-12-31 | ₩19.67 Billion ≈ $13.33 Million |
-14.76% |
| 2018-12-31 | ₩23.07 Billion ≈ $15.64 Million |
+38.33% |
| 2017-12-31 | ₩16.68 Billion ≈ $11.30 Million |
+49.28% |
| 2016-12-31 | ₩11.17 Billion ≈ $7.57 Million |
-- |
About KNOTUS Co.Ltd
HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more